vs

Side-by-side financial comparison of HARROW, INC. (HROW) and Porch Group, Inc. (PRCH). Click either name above to swap in a different company.

Porch Group, Inc. is the larger business by last-quarter revenue ($121.1M vs $89.1M, roughly 1.4× HARROW, INC.). HARROW, INC. runs the higher net margin — 7.4% vs -3.9%, a 11.3% gap on every dollar of revenue. On growth, Porch Group, Inc. posted the faster year-over-year revenue change (100.0% vs 33.3%). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 26.4%).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

Porch is a website that tries to connect homeowners with local home improvement contractors. The site features advice articles, cost guide, and online booking for over 160 home projects.

HROW vs PRCH — Head-to-Head

Bigger by revenue
PRCH
PRCH
1.4× larger
PRCH
$121.1M
$89.1M
HROW
Growing faster (revenue YoY)
PRCH
PRCH
+66.7% gap
PRCH
100.0%
33.3%
HROW
Higher net margin
HROW
HROW
11.3% more per $
HROW
7.4%
-3.9%
PRCH
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
26.4%
PRCH

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HROW
HROW
PRCH
PRCH
Revenue
$89.1M
$121.1M
Net Profit
$6.6M
$-4.7M
Gross Margin
79.3%
52.7%
Operating Margin
17.5%
34.7%
Net Margin
7.4%
-3.9%
Revenue YoY
33.3%
100.0%
Net Profit YoY
-2.2%
2.0%
EPS (diluted)
$0.20
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
PRCH
PRCH
Q1 26
$121.1M
Q4 25
$89.1M
$112.3M
Q3 25
$71.6M
$115.1M
Q2 25
$63.7M
$107.0M
Q1 25
$47.8M
$84.5M
Q4 24
$66.8M
$75.3M
Q3 24
$49.3M
$77.7M
Q2 24
$48.9M
$75.9M
Net Profit
HROW
HROW
PRCH
PRCH
Q1 26
$-4.7M
Q4 25
$6.6M
$-3.5M
Q3 25
$1.0M
$-10.9M
Q2 25
$5.0M
$2.6M
Q1 25
$-17.8M
$8.4M
Q4 24
$6.8M
$30.5M
Q3 24
$-4.2M
$14.4M
Q2 24
$-6.5M
$-64.3M
Gross Margin
HROW
HROW
PRCH
PRCH
Q1 26
52.7%
Q4 25
79.3%
99.5%
Q3 25
75.3%
75.6%
Q2 25
74.5%
70.9%
Q1 25
67.5%
77.4%
Q4 24
78.8%
Q3 24
75.6%
79.4%
Q2 24
74.4%
22.1%
Operating Margin
HROW
HROW
PRCH
PRCH
Q1 26
34.7%
Q4 25
17.5%
14.7%
Q3 25
20.6%
14.2%
Q2 25
17.9%
4.7%
Q1 25
-23.5%
-1.5%
Q4 24
19.3%
33.3%
Q3 24
2.7%
-3.2%
Q2 24
3.1%
-69.2%
Net Margin
HROW
HROW
PRCH
PRCH
Q1 26
-3.9%
Q4 25
7.4%
-3.1%
Q3 25
1.4%
-9.4%
Q2 25
7.8%
2.4%
Q1 25
-37.2%
9.9%
Q4 24
10.1%
40.5%
Q3 24
-8.6%
18.5%
Q2 24
-13.2%
-84.8%
EPS (diluted)
HROW
HROW
PRCH
PRCH
Q1 26
$-0.04
Q4 25
$0.20
$0.00
Q3 25
$0.03
$-0.10
Q2 25
$0.13
$0.00
Q1 25
$-0.50
$0.07
Q4 24
$0.19
$0.34
Q3 24
$-0.12
$0.12
Q2 24
$-0.18
$-0.65

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
PRCH
PRCH
Cash + ST InvestmentsLiquidity on hand
$72.9M
$68.4M
Total DebtLower is stronger
$250.0M
$391.3M
Stockholders' EquityBook value
$52.4M
$26.3M
Total Assets
$399.5M
$806.6M
Debt / EquityLower = less leverage
4.77×
14.87×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
PRCH
PRCH
Q1 26
$68.4M
Q4 25
$72.9M
$57.3M
Q3 25
$74.3M
$85.0M
Q2 25
$53.0M
$79.8M
Q1 25
$66.7M
$70.4M
Q4 24
$47.2M
$191.7M
Q3 24
$72.6M
$238.6M
Q2 24
$71.0M
$308.4M
Total Debt
HROW
HROW
PRCH
PRCH
Q1 26
$391.3M
Q4 25
$250.0M
$392.8M
Q3 25
$347.2M
$387.1M
Q2 25
$250.6M
$394.1M
Q1 25
$256.9M
$409.2M
Q4 24
$262.7M
$403.9M
Q3 24
$230.7M
$399.0M
Q2 24
$236.3M
$436.8M
Stockholders' Equity
HROW
HROW
PRCH
PRCH
Q1 26
$26.3M
Q4 25
$52.4M
$-24.6M
Q3 25
$47.0M
$-27.9M
Q2 25
$49.7M
$-29.3M
Q1 25
$56.5M
$-52.4M
Q4 24
$69.7M
$-43.2M
Q3 24
$58.0M
$-77.0M
Q2 24
$58.5M
$-101.9M
Total Assets
HROW
HROW
PRCH
PRCH
Q1 26
$806.6M
Q4 25
$399.5M
$797.4M
Q3 25
$363.1M
$787.7M
Q2 25
$345.0M
$770.7M
Q1 25
$364.2M
$802.3M
Q4 24
$389.0M
$814.0M
Q3 24
$351.5M
$867.3M
Q2 24
$306.6M
$876.1M
Debt / Equity
HROW
HROW
PRCH
PRCH
Q1 26
14.87×
Q4 25
4.77×
Q3 25
7.39×
Q2 25
5.05×
Q1 25
4.55×
Q4 24
3.77×
Q3 24
3.98×
Q2 24
4.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
PRCH
PRCH
Operating Cash FlowLast quarter
$8.4M
Free Cash FlowOCF − Capex
$8.1M
FCF MarginFCF / Revenue
9.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
1.27×
TTM Free Cash FlowTrailing 4 quarters
$43.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
PRCH
PRCH
Q1 26
Q4 25
$8.4M
$1.2M
Q3 25
$16.6M
$40.8M
Q2 25
$-803.0K
$35.6M
Q1 25
$19.7M
$-11.2M
Q4 24
$-17.8M
$-26.6M
Q3 24
$3.0M
$12.4M
Q2 24
$-2.7M
$-26.0M
Free Cash Flow
HROW
HROW
PRCH
PRCH
Q1 26
Q4 25
$8.1M
$1.1M
Q3 25
$16.4M
$40.7M
Q2 25
$-969.0K
$35.4M
Q1 25
$19.5M
$-11.2M
Q4 24
$-18.3M
$-26.8M
Q3 24
$2.3M
$12.2M
Q2 24
$-3.1M
$-26.0M
FCF Margin
HROW
HROW
PRCH
PRCH
Q1 26
Q4 25
9.1%
1.0%
Q3 25
22.9%
35.4%
Q2 25
-1.5%
33.0%
Q1 25
40.8%
-13.3%
Q4 24
-27.4%
-35.6%
Q3 24
4.8%
15.7%
Q2 24
-6.3%
-34.3%
Capex Intensity
HROW
HROW
PRCH
PRCH
Q1 26
Q4 25
0.4%
0.1%
Q3 25
0.3%
0.1%
Q2 25
0.3%
0.2%
Q1 25
0.4%
0.1%
Q4 24
0.8%
0.3%
Q3 24
1.2%
0.3%
Q2 24
0.7%
0.1%
Cash Conversion
HROW
HROW
PRCH
PRCH
Q1 26
Q4 25
1.27×
Q3 25
16.26×
Q2 25
-0.16×
13.79×
Q1 25
-1.33×
Q4 24
-2.62×
-0.87×
Q3 24
0.86×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons